HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.

National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

In a busy week that includes much-anticipated quarterly reports, a pair of standouts among the finance and aerospace sectors ...

Detailed price information for Paypal Holdings (PYPL-Q) from The Globe and Mail including charting and trades.

Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...

Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.

In the latest close session, Sensus Healthcare, Inc. (SRTS) was up +2.54% at $4.44. The stock's change was more than the S&P 500's daily gain of 0.54%. Meanwhile, the Dow experienced a rise of ...

RTX Corp. RTX is slated to release second-quarter 2025 results on July 22, before the opening bell.

Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...

Intuitive Surgical ISRG recently received FDA clearance for its Vessel Sealer Curved, a multifunctional instrument designed ...

A record flood of new cash. Leveraged and inverse products. Hedge-fund and private-equity firms getting in. Exchange-traded funds are the big investing story of the year.